Doctor profile · Federal record
Dr. Siddhartha Devarakonda, MD
Medical Oncology Physician (CMS: Medical Oncology) · Internal Medicine Physician · Hematology & Oncology Physician · Medical Oncology Physician · Seattle, WA
- NPI 1487932398
- Accepts Medicare
- MIPS 79.3 / 100 · 2023
- 17 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1221 Madison St Fl 2
Seattle, WA 981043588
(206) 386-2323
fax (206) 215-6165 - Mailing address
-
Po Box 25608
Salt Lake City, UT 841250608
Credentials & registration
- NPI registered
- July 2011 — 15 yrs on file
- Profile last updated
- May 24, 2023
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State licenses (2)
- Washington #MD61372698 · Missouri #2014039433
- Medicaid
- WA #2238079
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1487932398. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
199
Distinct HCPCS
3
Medicare allowed
$32,147
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 132 | 38 | $155 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 52 | 52 | $195 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 15 | 11 | $105 |
In context: peer comparison
Among 18 peers in Seattle Medical Oncology Physician, average services per provider: 51. This provider delivers 3.9× the peer median.Open Payments
Industry payments received
All-time total
$67,037
Transactions
60
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 24 | $29,525.07 | |
| Janssen Biotech, INC. | 21 | $21,163.92 | |
| Acrotech Biopharma INC. | 7 | $5,530.80 | |
| Takeda Pharmaceuticals U.S.A., INC. | 1 | $4,398.75 | |
| Daiichi Sankyo INC. | 6 | $4,198.82 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $2,220.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
137
Patients
37
Total drug cost
$564,330
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Tagrisso (Osimertinib Mesylate) | Brand | 32 | 11 | $549,578 |
| Eliquis (Apixaban) | Brand | 20 | 0 | $13,823 |
| Dexamethasone | Generic | 18 | 14 | $220 |
| Pantoprazole Sodium | Generic | 18 | 0 | $160 |
| Prednisone | Generic | 17 | 12 | $105 |
| Gabapentin | Generic | 16 | 0 | $136 |
| Prochlorperazine Maleate | Generic | 16 | 0 | $308 |
Hospital affiliations
Frequently asked questions
What is Dr. Siddhartha Devarakonda's medical specialty?
Dr. Siddhartha Devarakonda practices Medical Oncology Physician in Seattle, WA.
Where does Dr. Siddhartha Devarakonda practice?
Dr. Siddhartha Devarakonda practices at 1221 Madison St Fl 2, Seattle, WA 981043588. Office phone: 2063862323.
What is Dr. Siddhartha Devarakonda's NPI?
Dr. Siddhartha Devarakonda's National Provider Identifier (NPI) is 1487932398, issued by NPPES.
Does Dr. Siddhartha Devarakonda accept Medicare assignment?
Yes. Dr. Siddhartha Devarakonda accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Siddhartha Devarakonda commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99215); New patient office or other outpatient visit (HCPCS 99205); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.